The 5 analysts offering 12-month price forecasts for Kintara Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +661.27% increase from the last price of 0.66.
The current consensus among 4 polled investment analysts is to Buy stock in Kintara Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.16
Reporting Date Feb 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.